Drug––diagnostic codevelopment strategies: FDA and industry dialog at the 4th FDA/DIA/PhRMA/PWG/BIO Pharmacogenomics Workshop

Author： Hinman Lois   Spear Brian   Tsuchihashi Zenta   Kelly James   Bross Peter   Goodsaid Federico   Kalush Francis  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.10, Iss.1, 2009-01, pp. : 127-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

4th US FDA––Drug Information Association pharmacogenomics workshop, held 10––12 December, 2007

By Frueh Felix W   Salerno Ronald A   Lesko Lawrence J   Hockett Richard D  

Pharmacogenomics, Vol. 10, Iss. 1, 2009-01 ,pp. : 111-115

Future Medicine

Access to resources Recommend Favorite

Drug-Diagnostic Co-Development in Cancer

By Winther Henrik  

Pharmaceutical Medicine, Vol. 24, Iss. 6, 2010-12 ,pp. : 363-375

Adis International

Access to resources Recommend Favorite

Adaptive Designs in Clinical Drug Development: Opportunities, Challenges, and Scope Reflections Following PhRMA's November 2006 Workshop

By Krams Michael  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 957-964

Taylor & Francis Ltd

Access to resources Recommend Favorite

DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA

By Lesko Lawrence J   Zineh Issam  

Pharmacogenomics, Vol. 11, Iss. 4, 2010-04 ,pp. : 507-512

Future Medicine

Access to resources Recommend Favorite

Guest Editors’ Note: Special Issue Associated With the 2013 ASA Biopharmaceutical FDA/Industry Statistics Workshop

By    

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 5, 2014-09 ,pp. : 965-967

Taylor & Francis Ltd

Access to resources Recommend Favorite